Autoimmune Diseases  >>  NN9828  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NN9828 / Almirall
NCT01208506: First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis

Checkmark P1 data - ACR/ARHP 2012 (RA)
Sep 2012 - Sep 2012: P1 data - ACR/ARHP 2012 (RA)
Completed
1
64
Europe
NNC0114-0000-0005, placebo
Novo Nordisk A/S
Inflammation, Rheumatoid Arthritis, Healthy
02/12
02/12
NCT01565408: Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis

Completed
1
32
Europe, RoW
NNC0114-0006, placebo
Novo Nordisk A/S
Inflammation, Rheumatoid Arthritis
10/13
10/13
NCT01689025: An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)

Terminated
1
10
US, Europe, RoW
NNC0114-0006, placebo
Novo Nordisk A/S
Inflammation, Systemic Lupus Erythematosus
02/14
02/14

Download Options